IL33 and Alzheimer disease: Keratinocytes produce more thymic stromal lymphopoietin, IL-33, and IL-25 in patients with AD, which activates ILC2cytokine expression in AD lesions to create IL-4, IL-5, and IL-13(Stier and Peebles 2017).